Home › Trial NCT05697406
HP Pyruvate MRI in Cancers
- Trial IDNCT05697406
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorUniversity of Maryland, Baltimore
- Enrollment25
- Start date2024-06-24
- ConditionsImage · Warburg Effect · Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.